Article ID Journal Published Year Pages File Type
5104542 Value in Health 2017 9 Pages PDF
Abstract
Considering the usually accepted thresholds in oncology, pembrolizumab is a cost-effective alternative for treating patients with advanced melanoma in Portugal.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal
Authors
, , , , , , ,